Oral GLP-1 agonist, Satiety Pathways, and Stem Cell tx for T1D

This week's topics include an oral GLP-1 agonist, activating two satiety pathways, mental health in US adolescents, and stem cell tx for T1D.

Program notes:

0:40 Stem cells for type 1 diabetes

1:40 None had hypoglycemia afterwards

2:40 Autologous stem cells?

3:20 Oral GLP-1 agonist

4:20 Primary endpoint HbA1c reduction

5:20 Weight loss modest

6:20 Injectable GLP-1 plus an amylin analogue

7:20 Both those with diabetes and those without

8:20 No increased safety events

8:40 Mental health hospitalizations in adolescents

9:40 KID database

10:40 Females accounting for increase

11:40 67% of hospitalizations

12:57 End